Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-04

Clinical Trial Update: Spinal Cord Stimulation For Heart Failure [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial of spinal cord stimulation for systolic heart failure conducted by Abbott Medical Devices has completed. No results are provided in the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spinal cord stimulation

Snippet

Sponsor: Abbott Medical Devices | Conditions: Systolic Heart Failure | Phase 2, Phase 3 | Status: COMPLETED